Elon Musk’s Neuralink gets FDA clearance for brain chip implant in second patient: Report

The US Food and Drug Administration (FDA) allowed another attempt at Neuralink, a neurotechnological implant by billionaire Elon Musk on Monday. As per the Wall Street Journal report, the implant had started showing issues in their first attempt.

Earlier this month, Neuralink reported that tiny wires implanted in the brain of its first patient had shifted out of position. According to Reuters last week, the company was aware of the phenomenon through animal testing that the wires might retract.